SMMT Shares Updated Ivonescimab Survival Data From NSCLC Study

Data ReadoutIvonescimabNeutral

AI Analysis

Summary

SMMT has shared updated survival data from an ivonescimab clinical trial in non-small cell lung cancer patients. Specific efficacy details and patient outcomes are not provided in the article.

Clinical Trial Data

Outcome Details

Updated survival data from NSCLC study

Importance:5/10

Sentiment:

0.00

oncologylung cancerclinical datasurvival data

Related Companies

$GSK

Read the original article

Published by yahoo_finance on July 23, 2026 2:31 PM

Read Original